Leviathyn.com chats with the Cannibal Fever team about their recent Kickstarter project. They are at PAX Australia to announce this somewhat stomach rattling but really unique zombie RTS game. Have a read:
Leviathyn.com: CAN YOU INTRODUCE US TO CANNIBAL FEVER?
Michael: Certainly. So my name is Michael Carroll and I work for Forbidden Film Studios, a local company in Melbourne, Australia. We’re here today at PAX AUS 2014 to announce the launch of the Kickstarter for our zombie RTS game Cannibal Fever which basically has a whole bunch of elements to it which I hope will make it really successful. We’re using live action, motion capture animation and we have great American voice talents such as John DiMaggio, Jim Cummings and Richard Doyle which I hope will make this game really cool sounding ans really immersive.
Leviathyn.com: DO YOU PLAN TO APPROACH THE RTS GENRE WITH A MORE WARCRAFT/STARCRAFT STYLE OR SHOULD WE BE THINKING MORE ALONG THE LINES OF COMMAND & CONQUER OR AGE OF EMPIRES?
M: I think we’re doing some slightly different things with our RTS. Obviously you get to play as the zombies and the issue with that is that zombies don’t really collect resources or build structures so we had to come up with a number of ways to make that work.
M: The world is preexisting and you will move your units around the map to capture key buildings. Those key buildings will then build more units or research new upgrades on a time basis – the bigger the unit or upgrade, the longer it takes. I was worried about this not working but then I remembered a game I played as a kid called Z by the Bitmap Brothers which basically had the same thing where you’ve got territories and it was really fast paced. You had to think about your strategy and be on top of all these different things and it made it really fast and I think that’s what we’re looking for in this game. Fast action that makes you feel immersed and slightly distressed – either you’re trying to kill hordes and hordes of zombies or you’re using your horde of zombies to kill them.